Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 174

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors

Open access
Leggett, James D, Aspley, S, Beckett, S R G, D'Antona, A M, Kendall, D A, Kendall, D A·2004·British Journal of Pharmacology

Abstract

The ability of the endogenous fatty acid amide, cis‐oleamide (ODA), to bind to and activate cannabinoid CB 1 and CB 2 receptors was investigated. ODA competitively inhibited binding of the nonselective cannabinoid agonist [3 H]CP55,940 and the selective CB 1 antagonist [3 H]SR141716A to rat whole‐brain membranes with Ki values of 1.14 μM (0.52–2.53 μM, Hill slope=0.80, n=6) and 2.63 μM (0.62–11.20 μM, Hill slope=0.92, n=4), respectively. AEA inhibited [3 H]CP55,940 binding in rat whole‐brain membranes with a Ki of 428 n M (346–510 n M, Hill slope=−1.33, n=3). ODA competitively inhibited [3 H]CP55,940 binding in human CB 1 (hCB 1) cell membranes with a Ki value of 8.13 μM (4.97–13.32 μM, n=2). In human CB 2 transfected (hCB 2) HEK‐293T cell membranes, 100 μM ODA produced only a partial (42.5±7%) inhibition of [3 H]CP55,940 binding. ODA stimulated [35 S]GTP γ S binding in a concentration‐dependent manner (EC 50=1.64 μM (0.29–9.32 μM), R2=0.99, n=4–9), with maximal stimulation of 188±9% of basal at 100 μM. AEA stimulated [35 S]GTP γ S binding with an EC 50 of 10.43 μM (4.45–24.42 μM, R2=1.00, n=3, 195±4% of basal at 300 μM). Trans‐oleamide (trans‐ODA) failed to significantly stimulate [35 S]GTP γ S binding at concentrations up to 100 μM. ODA (10 μM)‐stimulated [35 S]GTP γ S binding was reversed by the selective CB 1 antagonist SR141716A (IC 50=2.11 n M (0.32–13.77 n M), R2=1.00, n=6). The anatomical distribution of ODA‐stimulated [35 S]GTP γ S binding in rat brain sections was indistinguishable from that of HU210. Increases of similar magnitude were observed due to both agonists in the striatum, cortex, hippocampus and cerebellum. ODA (10 μM) significantly inhibited forskolin‐stimulated cyclic AMP (cAMP) accumulation in mouse neuroblastoma N1E 115 cells (P=0.02, n=11). ODA‐mediated inhibition was completely reversed by 1 μM SR141716A (P<0.001, n=11) and was also reversed by pretreatment with 300 ng ml−1 pertussis toxin (P<0.001, n=6). These data demonstrate that ODA is a full cannabinoid CB 1 receptor agonist. Therefore, in addition to allosteric modulation of other receptors and possible entourage effects due to fatty acid amide hydrolase inhibition, the effects of ODA may be mediated directly via the CB 1 receptor. British Journal of Pharmacology (2004) 141, 253–262. doi:10.1038/sj.bjp.0705607

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/sj.bjp.0705607

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 174

Metadata

Authors
Leggett, J. D., Aspley, S., Beckett, S. R. G., D'Antona, A. M., Kendall, D. A., & Kendall, D. A.
Venue
British Journal of Pharmacology
Publisher
Wiley
Published
2004-01
Volume
141
Issue
2
Pages
253-262
ISSN
  • 0007-1188 (ISSN-L)
  • 1476-5381
OpenAlex
W2103297906
Cited by
174
References
1
FWCI
8.80
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. https://app.cochat.ai/papers/10.1038/sj.bjp.0705607
The paper
Leggett, J. D., Aspley, S., Beckett, S. R. G., D'Antona, A. M., Kendall, D. A., & Kendall, D. A. (2004). Oleamide is a selective endogenous agonist of rat and human CB1 cannabinoid receptors. British Journal of Pharmacology. https://doi.org/10.1038/sj.bjp.0705607

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.